The spiny mouse (Acomys cahirinus) appears to be unique among mammals by showing little scarring or fibrosis after skin or muscle injury, but the Acomys response to spinal cord injury (SCI) is unknown. We tested the hypothesis that Acomys would have molecular and immunohistochemical evidence of reduced spinal inflammation and fibrosis following SCI as compared to C57BL/6 mice (Mus), which similar to all mammals studied to date exhibits spinal scarring following SCI. Initial experiments used two pathway-focused RT-PCR gene arrays ("wound healing" and "neurogenesis") to evaluate tissue samples from the C2-C6 spinal cord 3days after a C3/C4 hemi-crush injury (C3Hc). Based on the gene array, specific genes were selected for RT-qPCR evaluation using species-specific primers. The results supported our hypothesis by showing increased inflammation and fibrosis related gene expression (Serpine 1, Plau, Timp1) in Mus as compared to Acomys (P<0.05). RT-qPCR also showed enhanced stem cell and axonal guidance related gene expression (Bmp2, GDNF, Shh) in Acomys compared to Mus (P<0.05). Immunohistochemical evaluation of the spinal lesion at 4-wks post-injury indicated reduced collagen IV immunostaining in Acomys (P<0.05). Glial fibrillary acidic protein (GFAP) and ionized calcium binding adaptor molecule 1(IBA1) immunostaining indicated morphological differences in the appearance of astrocytes and macrophages/microglia in Acomys. Collectively, the molecular and histologic results support the hypothesis that Acomys has reduced spinal inflammation and fibrosis following SCI. We suggest that Acomys may be a useful comparative model to study adaptive responses to SCI.
Introduction
A fundamental goal of regenerative medicine is to develop therapies to reduce inflammation, fibrosis, scarring, or other detrimental outcomes in damaged or diseased mammalian tissues.
Spinal cord injury (SCI) is one condition in which inflammation, scarring, and limited regeneration has severe functional consequences. Immediately after SCI an inflammatory response is induced involving activation of resident immune cells (e.g. microglia), and recruitment of monocyte/macrophages and neutrophils to the site of the injury (Carlson, Parrish, Springer, Doty, & Dossett, 1998; Hawthorne & Popovich, 2011) . At later time points, a glial/fibrotic scar forms and provides a barrier that prevents axonal regeneration (Tran, Warren, & Silver, 2018) . Current regenerative therapies in SCI include delivery of exogenous stem cells (Pereira, Marote, Salgado, & Silva, 2019) and/or the incorporation of biomolecular scaffolds into the damaged spinal cord (Kim, Park, & Choi, 2014) . However, regenerative failure remains a consistent feature of SCI in animal models and humans.
One contributing factor to the lack of progress in identifying therapeutic targets has been the absence of a relevant model system, namely an adult mammal with high regenerative capacity of spinal tissue. In this regard, we recently discovered that the adult spiny mouse (Acomys cahirinus) can regenerate a remarkable range of tissues following injury including dermis, hair follicles, sebaceous glands, smooth muscle, skeletal muscle, adipose cells and cartilage (Brant, Yoon, Polvadore, Barbazuk, & Maden, 2016; Seifert et al., 2012) . Acomys does not undergo fibrosis in response to damage in any organ examined thus far, and presents a unique opportunity to interrogate the mechanisms involved in mammalian tissue regeneration (Pinheiro, Prata, Araújo, & Tiscornia, 2018) . A mammalian model of improved regenerative capacity after SCI would provide an opportunity for comprehensive examination of the mechanisms contributing to this response. Towards this goal, we evaluated the acute molecular and long-term immunohistochemical impact of SCI in Acomys. This response was compared to Mus, which displays signatures of the "typical" mammalian response to spinal injury (i.e. inflammation, scarring, limited regeneration). The overall hypothesis was that the injured spinal cord in adult Acomys would have a molecular and immunohistochemical signature consistent with reduced fibrosis and improved regenerative capacity as compared to Mus.
Materials and methods
Animals. All experiments were conducted with adult, male C57/BL6 (n=16; 29.8 ± 2.8g) mice (Mus; Jackson Laboratory) and male, spiny mice (n=15; 45.1 ± 6.4g) (Acomys cahirinus; in-house colony at the University of Florida). Descriptions of skin and muscle wound healing using spiny mice from this colony have been published (Brant, Lopez, Baker, Barbazuk, & Maden, 2015; Brant et al., 2016; Maden et al., 2018) . Mice were housed in a controlled environment (12h light/dark cycles) with food and water ad libitum. All experimental protocols were approved by the Institutional Animal Care and Use Committee at the University of Florida.
Spinal Cord Injury. Anesthesia was induced by placing mice in a chamber flushed with 3% isoflurane mixed with 100% O2. Anesthetized mice were transferred to a heated surgical station and core body temperature was maintained at 37.5 ± 0.5°C (model 700 TC-1000, CWE). During surgery, anesthesia was maintained by having the mice breathe 1.5-2% isoflurane through a nose cone with 100% O2. The surgical area was cleaned with three, alternating rounds of betadine surgical scrub followed by 70% ethanol. A dorsal incision was then made over the spinal midline from the base of the skull to the fifth cervical segment. A C3 laminectomy was performed to expose the spinal cord, and a C3 lateral, dorsal crush injury was induced similar to previous report (Hilton et al., 2013) . A sterilized pair of fine tipped Dumont #5 forceps was marked 1mm from the tip with a black sharpie marker. To induce the injury, one prong of the forceps was inserted at the spinal midline at a depth of 1mm (identified by the black sharpie mark) while the other prong remained outside the lateral edge of the spinal cord. The forceps were held closed for 15 seconds.
The forceps were removed, reinserted for a second time and closed again for 15 seconds.
Following the injury, the overlying muscles were sutured with 4-0 Vicryl suture and the skin was closed with sterile wound clips. Mice received an analgesic, buprenorphine (0.03 mg/kg, s.q.) and nonsteroidal anti-inflammatory medication meloxicam (2.0 mg/kg, s.q.) for the initial 48 hours post-injury. Mice also received Lactated Ringer's solution (2 ml/day, s.q.) and oral Nutri-cal supplements (0.5-1ml, Webster Veterinary, MA, USA) until adequate volitional eating and drinking resumed. Manual bladder expression was performed twice daily until voluntary micturition was apparent. The bladder size was estimated by palpating the lower abdomen using two fingers (thumb and index finger) and was then expressed by gently applying pressure until the bladder was completely emptied. Body temperature was assessed daily for two weeks post-SCI using a digital mouse rectal thermometer (model 700 TC-1000, CWE) and Vaseline.
Gene Arrays. Three days post-SCI (Mus: n=6, Acomys: n=5) or age matched controls not receiving an injury (Mus: n=4, Acomys: n=5), mice were anesthetized by breathing 3% isoflurane mixed into 100% O2. The mice then received an i.p. injection of beuthanasia solution (150mg/kg). The depth of anesthesia was confirmed via lack of foot withdrawal to toe pinch, and the cervical spinal cord from C2 to C6 was quickly extracted, placed in an ice cold RNA free dish, cut sagittally to isolate the ipsilateral (same side as injury) spinal cord and immediately placed into 1.5mL of RNALater (Qiagen Cat. 76104). Spinal cord samples were stored at 4°C for 24 hours and then maintained at -80°C. Tissues were subsequently thawed at 4°C, washed in RNase-free water and homogenized using a rotor stator type tissue homogenizer (ProScientific Bio-Gen PRO200 Homogenizer; Multi-Gen 7XL Generator Probes) in RLT Buffer and processed using the Rneasy Plus Mini Kit (Qiagen Cat. 74134). RNA quality was assessed using an Agilent 2200 TapeStation (Agilent, Andover, MA). All samples had a RIN score > 7.0. For the wound healing pathwayfocused RT-PCR array (Qiagen PAMM-121Z) and the neurogenesis pathway-focused RT-PCR array (Qiagen PAMM-404Z) cDNA was generated using the RT 2 PreAMP cDNA Synthesis Kit (Qiagen 330451), using array specific primers (Qiagen 330241) followed by the RT 2 First Strand Kit (Qiagen 33041). Arrays were run using RT 2 SYBR Green qPCR Mastermix (Qiagen 330502).
For RT-qPCR with species-specific primers cDNA was generated SuperScript™ IV VILO Reverse Transcriptase (Invitrogen 11756050) following the manufacturer's protocol. Real-Time PCR was performed using Sso-Fast™ EvaGreen® Supermix (Bio-Rad 172-5200) on a Bio-Rad C1000 Touch™ Thermal Cycler. The fold change in gene expression was calculated using the ΔΔCt relative expression method (Livak & Schmittgen, 2001) using Gapdh as the reference gene.
Sequence of species-specific PCR primers can be found in Supplemental Table 1 . All reactions were run with an annealing temperature of 60°C.
Antibody Selection: Antibody name, source, catalog number, concentration, immunogen, and research resource identifiers (RRID) for each primary antibody used in the study are provided in Table 1 . The polyclonal, Collagen IV antibody (Abcam, Cat#ab6586; RRID: AB_305584; sequence available here: https://www.uniprot.org/uniprot/P02462) was validated by the manufacturer and binds to native collagen epitopes composed of multiple subunit strands and has negligible cross-reactivity with Type I, II, III, V or VI collagens. Specifically, Collagen IV has been shown to accumulate within the scar following SCI (Liesi & Kauppila, 2002) . This antibody detects a single band ~250kDa on western blots in baby hamster kidney fibroblasts (Abcam, 2012) , and has an expression pattern following SCI in mouse (Vangansewinkel et al., 2019) and rat (Tuinstra et al., 2014) (Mullen, Buck, & Smith, 1992) . We have previously used the polyclonal, Glial Fibrillary Acidic Protein (GFAP) antibody (EnCor Biotechnology, Cat#CPCA-GFAP; RRID: AB_2109953; sequence available here: https://www.uniprot.org/uniprot/P14136) to stain reactive astrocytes in mouse brain and spinal tissue during CNS disease (S. M. . Similar to other reports (Bovolenta, Wandosell, & Nieto-Sampedro, 1992; Cregg et al., 2014) , GFAP is a major constituent of the astro-glial scar in most mammals which forms following SCI. Western blot analysis of whole brain lysates indicates GFAP antibody shows a single, strong band at ~50kDa.
Immunohistochemistry.
A separate cohort of mice that recovered for four weeks following SCI mice (Mus: n=6, Acomys: n=5) were anesthetized by breathing 3% isoflurane mixed into 100%
O2 followed by an i.p. injection of urethane solution (1.0-1.6g/kg in distilled water). After the depth of anesthesia was verified, mice were transcardially perfused with ice cold saline (1ml per gram body weight) followed by 4% paraformaldehyde (PFA; 1ml/g) in 1X Dulbecco's phosphate buffered saline (DPBS, Mediatech, Inc., Cat#21-030-CV). The cervical spinal cord (C2-C6) was harvested, post-fixed in 4% PFA overnight at 4°C and placed in 70% ethanol at room temperature for at least 48 hrs. The spinal cord was then paraffin embedded and stored at room temperature.
Paraffin embedded spinal cords were cut longitudinally at 7 µm on a Leica Biosystems microtome and mounted on glass slides (Fisher, Superfrost Plus). Alternate slides were then used for immunostaining, and this enabled each stain to be evaluated at 35µm increments (i.e., every 5 th slide was stained).
Prior to immunochemistry, tissue sections were deparaffinized and rehydrated through xylenes followed by a graded series of ethanol exposures (100%, 95% and 70%). An antigen retrieval procedure was done using 0.1M Citrate solution, pH 6.0 for 25 minutes (collagen IV/MBP staining;
Abcam) or Trilogy reagent (IBA1/GFAP/NeuN staining; Cell Marque) at 95 °C for 15 min. Slides were blocked in 2% normal horse serum (Vector Labs) in 1X TBS with 0.2% Triton-X for 1hr at room temperature. Spinal sections were then incubated for two days at 4°C in the primary antibody solution (Table1): rabbit anti-collagen IV (1:250; RRID: AB_305584), chicken anti-MBP (1:500; RRID: AB_2572352), rabbit anti-Iba-1 (1:300; RRID: AB_839504), mouse anti-NeuN
(1:1,000; RRID: AB_2572267), chicken anti-GFAP (1:1,000; RRID: AB_2109953), in antibody diluent (ThermoFisher Scientific, #003118 
Results
Behavioral observations. Several relevant observations were made during the routine care of the animals following SCI (Figure 1) . First, Acomys resumed spontaneous bladder voiding earlier than Mus ( Figure 1A) . Acomys regained the ability to void the bladder by two days post-injury whereas
Mus required manual bladder expression for more than two weeks. Second, both species showed a transient weight loss after the injury, but with a different time course as illustrated in Figure 1B .
Mus showed an immediate drop in body mass, whereas Acomys did not drop body mass until day three. Prior to injury, body temperature was different between Mus (n=6; 37.6±0.1°) and Acomys (n=7; 35.7±0.2°, P<0.0001). Differences were also noted in rectal temperature over the first few days following the injury. Acomys showed an increase of approximately 1ºC during days 1-7 postinjury whereas Mus slightly dropped temperature ( Figure 1C ).
RT-PCR arrays.
For an initial comparison of the molecular genetic response to SCI in Mus vs.
Acomys, we examined the expression profile of the ipsilesional cervical spinal cord (C2-C6) at three days post-SCI (relative to non-injured controls) using two different pathway-focused RT-PCR arrays. These initial experiments were intended to identify genes of interest and individual genes were subsequently validated with RT-qPCR quantitation using both Mus-specific and Acomys-specific primers (next section). The first gene array targeted 84 genes involved in wound healing (e.g., inflammation, granulation, tissue remodeling) and the second array evaluated 84 genes associated with neurogenesis (e.g., proliferation, differentiation, motility, migration) and stem cell differentiation.
The results of the wound healing array and neurogenesis array are presented in Supplemental Table 2a ). The upregulated genes in Mus can be associated into four groups: 1) pro-inflammatory cytokines involved in the immune response to wounding (Il6, Cxcl3, Ccl12, Ccl7, Tnf, and Il1b); 2) ECM and its remodeling (Timp1, Itga5, Plaur, Mmp1a, Col5a3, and Plau); 3) Tgfβ1 signaling and fibrosis (Serpine1, Tagln and Tgfb1); and 4) a growth factor (Hgf). In contrast, upregulated genes in Acomys consisted of one inflammatory response gene (Tnf) and two genes associated with the ECM and cell surface (Col 5a1 and Cadherin1).
The majority of gene changes in Acomys were in the negative direction including extracellular matrix constituents (Vtn and Clo4a3), a vitronectin receptor (Itgav), inflammatory cytokines (Cxcl3 and Il2) and receptor (Il6st), and two integrins (Itgb5 and Itgb6).
In stark contrast to the wounding arrays, the majority of the upregulated genes in neurogenesis arrays were observed in Acomys. Specifically, there were 22 upregulated genes and three downregulated in Acomys, whereas in Mus there were seven upregulated genes and 42 downregulated ( Supplemental Table 2b ). The upregulated genes in Mus were Tgfb1, two growth factors (Gdnf and Fgf2), a transcriptional activator of growth factors (Stat3), a neuregulin receptor (Erbb2), and two genes involved in the regulation of actin cytoskeleton and cell motility (S100a6 and Flna). Four of these seven were also upregulated in Acomys. The 22 Figure 2b ). Analysis of Timp1, an extracellular matrix enzyme which functions to inhibit the action of the matrix metalloproteases was highly upregulated in Mus (t(4)=27.75, P<0.0001; Figure 2c .). Itgb5, an integrin that interacts with the matrix and intracellular compartments was similar between Mus and Acomys, which was supported by statistical analysis (t(4)=1.405, P=0.1163; Figure 2d ).
We also selected eight growth factor, neural stem cell, and signaling molecules genes identified by the neurogenesis array and verified their expression in both Mus and Acomys following SCI:
Bmp2, GDNF, Shh, Tgfβ1, Stat3, Notch1, Notch2, and Sox2 (Figure 3 ). Bmp2 and GDNF, which regulate cellular differentiation (Xiao, Du, Wu, & Yip, 2010) and growth (Rosich, Hanna, Ibrahim, Hellenbrand, & Hanna, 2017) were upregulated in Acomys compared to Mus ((t(4)=4.936, P=0.0039; Figure 3a ) and (t(4)=4.458, P=0.0056; Figure 3b) ). Shh, a morphogen that aids in progenitor proliferation (Bambakidis, Wang, Franic, & Miller, 2003) and myelination (Thomas & Shea, 2013) was also upregulated in Acomys (t(4)=3.883, P=0.0089; Figure 3c ). As observed in both gene arrays, levels of Tgfβ1 were similar between Mus and Acomys (t(4)=0.7728, P=0.2414; Figure 3d ). Although a trend for upregulation, there was no difference in the transcription factor Stat3 (t(4)=1.696, P=0.0826; Figure 3e ). Notch signaling, known to regulate neural progenitor cell fate (Cardozo, Mysiak, Becker, & Becker, 2017) was similar between Mus and Acomys (Notch1:
(t(4)=0.8279, P=0.2271; Figure 3f ); Notch2: (t(4)=0.2466, P=0.4087; Figure 3g) ). Sox2, a transcription factor related to neuronal differentiation was not different between species (t(4)=1.373, P=0.1208; Figure 3g ). Figure 4J ).
In contrast to collagen IV, the density of MBP within the spinal lesion appeared greater in Acomys.
The intensity of MBP staining (a.u.) was similar between species (F(1,27)=0.105, P=0.748), but different across location (F(2,27)=3.52, P=0.0438). Inspection of the data distribution indicated a possible difference in the dorsal spinal cord ( Figure 4K ). This is more evident when MBP is expressed relative to the lesion area ( Figure 4L ), as follows: location, F(2,27)=6.644, P=0.005; species, F(1,27)=3.474, P=0.073. Post hoc tests indicate differences in the dorsal spinal cord with greater staining in Acomys as compared to Mus (P=0.026; Figure 4L ).
Photomicrographs of GFAP immunostaining in Acomys and Mus are provided in Figure 5A -F with heat maps shown in Figure 5G -H. Evaluation of the immunohistochemical sections indicated differences between the two groups. Specifically, in Mus, GFAP positive astrocytes had a hypertrophied morphology and were concentrated at the lesion epicenter ( Figure 5A ), characteristic of reactive gliosis (Wilhelmsson et al., 2004) . In Acomys GFAP positive astrocytes were organized in a network near the spinal lesion ( Figure 5D ). The distribution of GFAP staining intensity across all spinal cords is shown in Figure 5I- Photomicrographs depicting IBA1 immunostaining and associated heat maps are provided in Figure 6A -H. Visual inspection suggested morphological differences between groups.
Specifically, in Mus spinal cords, IBA1 positive cells demonstrated a large, rounded appearance ( Figure 6C ) that is consistent with activated macrophages/microglia (Wu et al., 2005) . In Acomys, IBA1 positive cells were smaller as shown in Figure 6F . The distribution of staining intensity is shown in Figure 6I -J. These data were generally similar between the species, with possible suggestion of reduced IBA1 intensity in the middle spinal cord sections of Acomys as compared 
DISCUSSION
These experiments indicate that the African spiny mouse, Acomys, has a unique molecular and immunohistochemical response to SCI. In specific, three times the number of neurogenesis related genes were induced in Acomys as compared to Mus and these results stand in sharp contrast to the wound healing arrays where many pro-inflammatory and fibrosis related genes were induced only in Mus. The Acomys reaction to SCI is consistent with a reduced inflammation and fibrosis observed in our studies on skin regeneration using wound healing arrays (Brant et al., 2015) , antibody arrays (Brant et al., 2016) and transcriptome analyses (Brant et al., 2019) .
Thus, we conclude that the blunted immune response and lack of fibrosis in Acomys also extends to the injured spinal cord and may be a feature of any tissue damage inflicted upon this species.
In contrast, the Mus response is typical of wounding in most mammals, namely the generation of a pro-inflammatory environment by the production of cytokines secreted by leukocytes, neutrophils, macrophages, microglia, and fibroblasts. These cytokines attract additional blood cells and macrophages to the wound site and can assist with the induction of neurotrophins (Fan et al., 2018) , but excess levels cause scarring (Werner & Grose, 2003) . This self-reinforcing system can induce fibrosis and subsequent inhibition of axonal regrowth across a spinal lesion.
Conversely, in the absence of this "cytokine storm", as it has been referred to (Tisoncik et al., 2012) , the spinal environment in Acomys may be more conducive to regeneration.
In addition to the induction of pro-inflammatory cytokines, the majority of the remaining genes in
Mus can be linked together through transforming growth factor-β (TGFβ) and the extracellular matrix (ECM) in the development of a fibrotic response. One of the most highly upregulated genes in Mus was Timp1, which functions to inhibit the action of the matrix metalloproteases. The same phenomenon was seen in Mus skin wound arrays (Brant et al., 2016) , suggesting that the fibrotic response of Mus to wounding involves the inhibition of MMPs which may generate a more rigid ECM. The interaction of this rigid matrix with the intracellular compartment occurs via the integrins and the upregulation of integrins (e.g. Itgα5, along with Itgα1 -a receptor for fibronectin and fibrillin-1), could signal a fibrotic response to cells at the wound site. Activation of the TGFβ signaling pathway is also a key event in fibrosis (Schachtrup et al., 2010) . Serpine1 expression is promoted by TGFβ1 (Honda et al., 2017; Samarakoon & Higgins, 2008) and it is the major physiological regulator of the plasmin based cascade which is involved in fibrotic disorders of the vascular system and several organs such as skin, liver, lung and kidney. Serpine1 is also itself a pro-inflammatory molecule as it activates macrophages (Gupta et al., 2016) . Another plasminogen activator involved in the fibrotic pathway (He et al., 2018) upregulated following SCI in Mus was Plau, which could supplement the effects of Serpine1 on fibrosis. In addition to the role these TGFβ1 induced genes play in fibrosis, the activity of plasmin generated by their proteolytic activity is also involved in proteolysis of the ECM which itself could release TGFβ (Deryugina & Quigley, 2012) . Interestingly, the TGFβ1 gene was induced to the same degree in the spinal tissue of Mus and Acomys in both the wound and neurogenesis arrays, and also in our skin regeneration experiments (Brant et al., 2015) . This observation suggests that posttranscriptional mechanisms are involved in TGFβ1 and fibrotic responses such as its release from the matrix by biomechanical forces or the induction of downstream targets.
In addition to reduced fibrosis-related signaling, following SCI Acomys exhibit an upregulation of molecules associated with neurogenesis and regeneration including Bmp2, Shh, GDNF, and a tendency for elevated Notch 1 and Stat3 levels. This response involves signaling pathways identified in other model systems such as salamanders and zebrafish which successfully regenerate spinal tissue after injury. Specifically, Wnt, BMP and Hh pathways as well as several growth factors have been implicated in regulating the regenerative capacity of the spinal cord (Vergara, Arsenijevic, & Del Rio-Tsonis, 2005) . In mammals, these molecules are known to play important roles during development by establishing signaling gradients which control cellular differentiation, axonal guidance, and neurogenesis (Cardozo et al., 2017) .
Consistent with the molecular signature of the acutely injured Acomys spinal cord, we found a substantial reduction in staining for collagen IV in the vicinity of the spinal lesion after chronic injury in Acomys. Collagen is a major component of the fibrous scar that forms in the injured spinal cord (Hermanns, Klapka, & Müller, 2001; Stichel & Müller, 1998) . Collagen can be expressed by multiple cells types, including endothelial cells (Schwab, Beschorner, Nguyen, Meyermann, & Schluesener, 2001) , astrocytes (Liesi & Kauppila, 2002) and fibroblasts (Berry et al., 1983) , and is generally considered to be part of the barrier to growth of axonal projections after SCI (Klapka & Müller, 2006) . Another contribution to the glial scar comes from reactive astrocytes that express GFAP (Bovolenta et al., 1992) . Our evaluation of GFAP intensity in the chronically injured Acomys , 2019; Gensel & Zhang, 2015) . In our study, there was no suggestion of a difference in IBA1 staining intensity between the chronically injured Acomys and Mus spinal cords, which labels both macrophages and microglia (Imai, Ibata, Ito, Ohsawa, & Kohsaka, 1996) .
However, visual comparison of the IBA1 positive cells reveals Acomys have fewer, large, round IBA1 positive cells consistent with phagocytic morphology characteristic of activated microglia/macrophages (Wu et al., 2005) .
In summary, the molecular and histologic data presented here are consistent with a growing literature that indicates that Acomys has a tissue response to injury that may be relatively unique among mammals. Prior work definitively establishes that Acomys does not undergo fibrosis and has remarkable regenerative capacity in dermis, smooth muscle, skeletal muscle, and other tissue following injury (Brant et al., 2019; Brant et al., 2016; Jiang, Harn, Ou, Lei, & Chuong, 2019; Seifert et al., 2012) . Our current data support the hypothesis that this unique response to injury extends to the spinal cord. Based on the reduced inflammatory and fibrotic response and indication of enhanced regenerative capacity, we suggest that Acomys merits further study as comparative model to study adaptive responses to SCI. 
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